dimanche 15 novembre 2026
RechercherExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each, so you can check any claim. How we source
Source document· December 14, 2025

Trump's Fed pick comes into focus, economic data backlog clears: What to watch this week

View original at finance.yahoo.com
Trump's Fed pick comes into focus, economic data backlog clears: What to watch this week Stocks closed on Friday in the red, with the tech-heavy Nasdaq Composite (^IXIC) down roughly 1.7% while the blue-chip Dow Jones Industrial Average (^DJI) and benchmark S&P 500 (^GSPC) shed 0.5% and 1%, respectively…
Opening lines of the source · short snapshot: read the full document at the original

Ce que nous avons tiré de cette source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • There are a couple of other people besides Hassett and Warsh who are great Fed chair candidates

    80% confidence
  • There is a potential changing of the guard in the AI trade, with next big beneficiaries being businesses implementing the technology rather than chip manufacturers or hyperscalers

    80% confidence
  • The central question for Hassett nomination is whether Fed credibility will endure

    80% confidence
  • Kevin Hassett and Kevin Warsh are both great candidates for Fed chair

    80% confidence
  • USD weakening against other currencies is driven by news around the Fed's next leader

    80% confidence
  • Federal Reserve projects only one rate cut in 2026

    80% confidence
  • Debt issuance by hyperscalers represents a dramatic jump from pre-Covid levels

    80% confidence
  • Markets giving Hassett benefit of the doubt but perception that policy favors growth over price stability could risk unanchoring expectations

    80% confidence
Ce que nous savons · l'intelligence derrière cette page
En direct du substrat
Ce que nous observons
Q4 2026 Biotech Catalyst Cluster: Late-Stage Data and PDUFA Dates Converge
Early-to-mid November 2026 is a dense run of clinical readouts and Q3 earnings at AHA, AASLD, ACR and ASH. Mid-cap biotechs (Vir, Mineralys, Arrowhead, Oryzon, Novartis, J&J) are reporting data that feeds into regulatory decisions. The next ones are the ivonescimab BLA (Nov 14) and the lorundrostat PDUFA (Dec 22), followed by ECLIPSE 2/3 and Maritime-1 readouts in Q1 2027. The list also includes an unrelated delisting track (EGM Nov 19, application Jan 25, 2027), and the facts have no AI or fintech content.
Notre lecture des données ›
Signaux que nous suivons
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Tendances que nous surveillons ›
Là où les sources divergent
Sources réconciliées : aucun conflit ouvert pour l'instant.
Nous signalons les conflits ouvertement ›
Vérifié récemment
✓ Vérifié avec la source d'origine
4,959
faits reliés à leur source, et nous signalons ceux qui ne tiennent pas.
101 entités suivies4,959 faits vérifiés avec la source5,585 documents sources archivés
Interrogez ces données → isubstrate.com
Trump's Fed pick comes into focus, economic data backlog clears: What to watch this week: Source | Via News | fr.via.news